N22674
yx64a02.s1 Soares melanocyte 2NbHM Homo sapiens cDNA clone IMAGE:266474 3' similar to gb:K00558 TUBULIN ALPHA-1 CHAIN (HUMAN), mRNA sequence.
608
mRNA
Homo sapiens
LF829830
JP 2016528161-A/22663: COMBINATION THERAPY FOR TREATING HEARING AND BALANCE DISORDERS.
18
RNA
synthetic construct
HW187702
JP 2013102767-A/22626: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
MC551174
JP 2019525738-A/22674: BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES.
17
PRT
synthetic construct
DL904418
JP 2014205669-A/22674: Method of constructing and screening libraries of peptide structures.
27
PRT
synthetic construct
MC906412
JP 2018536623-A/22674: PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF.
35
PRT
synthetic construct
LF681895
JP 2016521556-A/22674: COMPOSITIONS AND METHODS FOR MODULATING FOXP3 EXPRESSION.
15
DNA
Homo sapiens
DL031688
JP 2005512499-A/22674: Diagnosis of existing illnesses or that praedisposition for determined illnesses.
1185
DNA
synthetic construct
OG659060
JP 2021500321-A/22674: METHODS AND COMPOSITIONS FOR INHIBITING ADAM10 BIOLOGICAL ACTIVITIES.
189
PRT
synthetic construct
HV879215
JP 2010507387-A/22626: Novel siRNAs and Methods of Use Thereof.
21
RNA
synthetic construct
HZ527455
JP 2016501039-A/22674: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
DM759368
JP 2014079248-A/22674: NEISSERIAL ANTIGENIC PEPTIDES.
5
PRT
Neisseria
MB763553
JP 2018535655-A/27450: ASGR INHIBITORS.
7
PRT
synthetic construct
PD710588
JP 2021530475-A/22670: De novo Design of Protein Switches.
58
PRT
synthetic construct
HW857898
JP 2015051004-A/22626: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
MD754916
JP 2019507579-A/22674: MATERIALS AND METHODS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY.
20
DNA
synthetic construct
PA338322
JP 2021522188-A/22674: Compositions and Methods for Multiplexed Tumor Vaccination with Endogenous Gene Activation.
20
DNA
synthetic construct
MC774784
JP 2018525446-A/22674: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF.
32
PRT
synthetic construct
LX120290
JP 2017506877-A/22672: Analysis of Nucleic Acids Associated With Single Cells Using Nucleic Acid Barcodes.
16
DNA
synthetic construct
LV568496
JP 2017029159-A/22674: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
DJ152054
JP 2007228956-A/22672: Method for identification of useful proteins derived from brewery yeast.
25
DNA
Saccharomyces pastorianus
DD802944
JP 2008525033-A/22674: Group B Streptococcus.
37
PRT
Streptococcus agalactiae
DD549277
JP 2004508801-A/22674: NEISSERIAL ANTIGENIC PEPTIDES.
5
PRT
Neisseria
MD268807
JP 2020517247-A/22674: A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof.
20
DNA
synthetic construct
MC164518
JP 2019500349-A/22674: COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES.
18
RNA
synthetic construct
PA393397
JP 2021533803-A/22480: FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE.
26
DNA
Homo sapiens
DM797132
JP 2014068652-A/22674: NEISSERIAL ANTIGENIC PEPTIDES.
5
PRT
Neisseria
DL613276
JP 2011092200-A/22674: NEISSERIAL ANTIGENIC PEPTIDES.
5
PRT
Neisseria
FU797155
JP 2009528046-A/22672: Method for identifying useful proteins of brewery yeast.
25
DNA
Saccharomyces pastorianus
PA527158
JP 2022502046-A/9940: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY.
21
DNA
synthetic construct